536: Prostate Cancer Mortality Following Introduction of Prostate Specific Antigen (PSA) Mass Screening in the Federal State of Tyrol, Austria: Follow-Up Until 2003

2005 ◽  
Vol 173 (4S) ◽  
pp. 146-146
Author(s):  
Georg C. Bartsch ◽  
Wolfgang Horninger ◽  
Wilhelm Oberaigner ◽  
Dieter Schönitzer ◽  
Helmut Klocker ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Mass Screening ◽  
Cancer Mortality ◽  
Specific Antigen ◽  
Federal State ◽  
Prostate Cancer Mortality

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

Urology ◽  
2001 ◽  
Vol 58 (3) ◽  
pp. 417-424 ◽  
Author(s):  
Georg Bartsch ◽  
Wolfgang Horninger ◽  
Helmut Klocker ◽  
Andreas Reissigl ◽  
Wilhelm Oberaigner ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Mass Screening ◽  
Cancer Mortality ◽  
Specific Antigen ◽  
Federal State ◽  
Prostate Cancer Mortality

Radical Prostatectomy Versus Observation in Early Prostate Cancer

2021 ◽  
pp. 31-36
Author(s):  
Philipp Dahm
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Prostate Specific Antigen ◽  
Cancer Mortality ◽  
Watchful Waiting ◽  
Specific Antigen ◽  
Prostate Cancer Mortality ◽  
Cancer Group

This chapter provides a summary of the landmark Scandinavian Prostate Cancer Group Study Number 4 trial of men with clinically localized prostate cancer from the pre–prostate-specific antigen (PSA) era who were randomized to radical prostatectomy versus watchful waiting and were followed long term. With follow-up of more than 20 years, the results favored surgery with regard to prostate cancer mortality.

Sign in / Sign up

Export Citation Format

Share Document